Novo Nordisk CEO Lars Fruergaard Jorgensen is stepping down per mutual agreement with the company. The company said Friday he will continue as CEO for a while to smooth the leadership transition.

Discussions between Novo Nordisk and the Novo Nordisk Foundation that controls the company regarding a CEO change have been ongoing for the past few weeks, the company's board…

Nel 2023 il colosso farmaceutico danese era diventato la maggiore società europea per capitalizzazione di mercato, superando il gruppo del lusso francese Lvmh